Real-world comparison of CAR T-cell therapy versus bispecific antibodies in relapsed or refractory multiple myeloma
Jia Yi Tan(APLA Health), Talal Hilal(Mayo Clinic in Florida), Daniel E. O’Leary(University of Minnesota), Nurliyanah Atiqah(Universiti of Malaysia Sabah), Aravinthan Vignarajah(Cleveland Clinic)
Cited by 0
Related Papers
How have US colorectal cancer mortality trends changed in the past 20 years?
|International Journal of Cancer|2024|21
Automated Classification and Analysis of Non-metallic Inclusion Data Sets
|Metallurgical and Materials Transactions B|2018|11
Social Vulnerability and Sickle Cell Disease Mortality in the US
|JAMA Network Open|2024|9
Photoactive Nanocrystals by Low‐Temperature Welding of Copper Sulfide Nanoparticles and Indium Sulfide Nanosheets
|ChemSusChem|2014|8
Pancreatic cancer mortality trends in the United States: how much have we moved the needle?
|Journal of Gastrointestinal Oncology|2024|7